Literature DB >> 15128760

Cutting edge: extracellular signal-regulated kinases 1/2 function as integrators of TCR signal strength.

Andrew E Schade1, Alan D Levine.   

Abstract

Altered signaling through the TCR is currently showing promise for immunotherapy. However, the molecular mechanisms are not completely understood. Therefore, we investigated whether varying the strength of TCR engagement in various human T cells would yield different second messenger responses. The kinetics and duration of extracellular signal-regulated kinase (ERK) activation, central to multiple cellular responses, are distinctly dependent on the T cell activation state (naive vs effector), strength of TCR cross-linking, and input from the phosphatidylinositol-3 kinase pathway, which is regulated by cytokines and growth factors. Moreover, the duration of ERK activation affects c-Fos expression, a component of the AP-1 transcription complex. Thus, the character of ERK activation, transient or sustained, acts as a signal integrator to quantify the strength of TCR engagement and direct the cellular response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128760     DOI: 10.4049/jimmunol.172.10.5828

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis.

Authors:  Andrew E Schade; Jennifer J Powers; Marcin W Wlodarski; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2006-02-16       Impact factor: 22.113

2.  Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.

Authors:  Andrew E Schade; Gary L Schieven; Robert Townsend; Anna M Jankowska; Vojkan Susulic; Rosemary Zhang; Hadrian Szpurka; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2007-10-25       Impact factor: 22.113

3.  Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells.

Authors:  Karmel A Allison; Eniko Sajti; Jana G Collier; David Gosselin; Ty Dale Troutman; Erica L Stone; Stephen M Hedrick; Christopher K Glass
Journal:  Elife       Date:  2016-07-04       Impact factor: 8.140

4.  A role for the immediate early gene product c-fos in imprinting T cells with short-term memory for signal summation.

Authors:  Carolyn E Clark; Milena Hasan; Philippe Bousso
Journal:  PLoS One       Date:  2011-04-28       Impact factor: 3.240

5.  Absence of the Adaptor Protein PEA-15 Is Associated with Altered Pattern of Th Cytokines Production by Activated CD4+ T Lymphocytes In Vitro, and Defective Red Blood Cell Alloimmune Response In Vivo.

Authors:  Stéphane Kerbrat; Benoit Vingert; Marie-Pierre Junier; Flavia Castellano; François Renault-Mihara; Silvina Dos Reis Tavares; Mathieu Surenaud; France Noizat-Pirenne; Jorge Boczkowski; Georges Guellaën; Hervé Chneiweiss; Sabine Le Gouvello
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

6.  Ligand-specific sequential regulation of transcription factors for differentiation of MCF-7 cells.

Authors:  Yuko Saeki; Takaho Endo; Kaori Ide; Takeshi Nagashima; Noriko Yumoto; Tetsuro Toyoda; Harukazu Suzuki; Yoshihide Hayashizaki; Yoshiyuki Sakaki; Mariko Okada-Hatakeyama
Journal:  BMC Genomics       Date:  2009-11-20       Impact factor: 3.969

7.  4-Hydroxy-17-methylincisterol from Agaricus blazei Decreased Cytokine Production and Cell Proliferation in Human Peripheral Blood Mononuclear Cells via Inhibition of NF-AT and NF-κB Activation.

Authors:  Wei-Jern Tsai; Shih-Chien Yang; Yu-Ling Huang; Chien-Chih Chen; Kai-An Chuang; Yuh-Chi Kuo
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-27       Impact factor: 2.629

8.  Computational investigations into the origins of short-term biochemical memory in T cell activation.

Authors:  Jason W Locasale
Journal:  PLoS One       Date:  2007-07-18       Impact factor: 3.240

9.  DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models.

Authors:  Yuki Kagoya; Munehide Nakatsugawa; Kayoko Saso; Tingxi Guo; Mark Anczurowski; Chung-Hsi Wang; Marcus O Butler; Cheryl H Arrowsmith; Naoto Hirano
Journal:  Nat Commun       Date:  2018-05-15       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.